Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2006 4
2007 2
2008 1
2009 1
2010 5
2011 11
2012 6
2013 9
2014 13
2015 10
2016 7
2017 8
2018 8
2019 9
2020 10
2021 12
2022 19
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 20942668

129 results

Results by year

Filters applied: . Clear all
Page 1
Tanezumab for the treatment of pain from osteoarthritis of the knee.
Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, Brown MT. Lane NE, et al. N Engl J Med. 2010 Oct 14;363(16):1521-31. doi: 10.1056/NEJMoa0901510. Epub 2010 Sep 29. N Engl J Med. 2010. PMID: 20942668 Free PMC article. Clinical Trial.
Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study.
Nagashima H, Suzuki M, Araki S, Yamabe T, Muto C; Tanezumab Investigators. Nagashima H, et al. Osteoarthritis Cartilage. 2011 Dec;19(12):1405-12. doi: 10.1016/j.joca.2011.09.006. Epub 2011 Oct 5. Osteoarthritis Cartilage. 2011. PMID: 22004765 Free article. Clinical Trial.
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT, West CR. Balanescu AR, et al. Ann Rheum Dis. 2014 Sep;73(9):1665-72. doi: 10.1136/annrheumdis-2012-203164. Epub 2013 Jul 12. Ann Rheum Dis. 2014. PMID: 23852695 Clinical Trial.
Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.
Schnitzer TJ, Khan A, Bessette L, Davignon I, Brown MT, Pixton G, Prucka WR, Tive L, Viktrup L, West CR. Schnitzer TJ, et al. Semin Arthritis Rheum. 2020 Jun;50(3):387-393. doi: 10.1016/j.semarthrit.2020.03.004. Epub 2020 Mar 19. Semin Arthritis Rheum. 2020. PMID: 32252976 Free article. Clinical Trial.
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
Berenbaum F, Blanco FJ, Guermazi A, Miki K, Yamabe T, Viktrup L, Junor R, Carey W, Brown MT, West CR, Verburg KM. Berenbaum F, et al. Ann Rheum Dis. 2020 Jun;79(6):800-810. doi: 10.1136/annrheumdis-2019-216296. Epub 2020 Mar 31. Ann Rheum Dis. 2020. PMID: 32234715 Free PMC article. Clinical Trial.
129 results